CYTORI THERAPEUTICS, INC. FORM DEF14A

Company

PLUS THERAPEUTICS, INC.

Filed

April 30, 2009

Period of Report

August 13, 2009

Accession Number

0001095981-09-000024

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →